at Nasdaq.com (Dec 4, 2014)
Medgenics (MDGN +3.2%) expands the range of patent coverage for its therapeutic proteins and thereby broadens the scope of its intellectual property as the company receives a notice of allowance from the U.S. Patent Office. MDGN now has 45 patents granted.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs